Project Grant R01DA064132
Award Date 9/1/25
Completion Date 5/31/30
Dollars Obligated $718K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Nebraska, USA
Similar Awards
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $608,652 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Scripps Research Institute. The purpose of this 5-year award, with a start date of September 1, 2025, is to conduct data mining and functional validation of the Systematic Characterization of Retroviral Conditions for Health (SCORCH) datasets. The research aims to elucidate the key pathogenic...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services' Drug Use and Addiction Research Programs (CFDA 93.279), provides $147,486 to the Icahn School of Medicine at Mount Sinai to investigate the combined impact of HIV infection and nicotine use on neuroinflammation. The research aims to elucidate the role of the NLRP3 inflammasome in driving CNS inflammation, blood-brain barrier disruption, and viral reactivation in...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, awarded a $639,920 project grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Board of Regents of the Nevada System of Higher Education, operating through the University of Nevada, Reno. The grant, which runs from September 15, 2025 to May 31, 2030, will fund a human laboratory study to examine the influence of "natural" cigarillo descriptors on expectancies, subjective...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $558,668 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Massachusetts Institute of Technology (MIT) for the project "Integration and Validation of Single-Cell Neuronal and Immune Molecular Responses in SUD and HIV". The project aims to uncover the genetic and molecular mechanisms driving the interactions between HIV, neuropsychiatric, and...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $363,310 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Vermont & State Agricultural College (UVM). The grant, titled "The Healthy Brain and Child Development Study's Scientific Training in Addiction Research Techniques Program (HBCD-START)," will provide comprehensive research education and training to prepare investigators to...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, awarded a $3,939,754 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Northern California Institute for Research and Education, Inc. (NCIRE) for the "Stimulant and Polysubstance Use, Inflammation and Sex Effects on Myocardial Disease in HIV (SPISE)" research program. The goal of this 5-year project, beginning July 15, 2025, is to investigate the role of stimulant...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $677,250 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Miami. The grant, awarded on June 15, 2025, supports the development and testing of the "Healthcare Empowerment and Advocacy for Recovery from Trafficking (HEART) Intervention" for implementation in syringe service programs. The project aims to engage women with experiences of...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $707,108 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Regents of the University of California, Berkeley (UC Berkeley) for the "International Development Project (IDP): An International Collaboration for the Standardized Study of Experience-Dependent Brain and Behavioral Development". The project aims to study the effects of various forms of...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, awarded a $426,036 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Tulane University. The award will fund a study to examine the feasibility and acceptability of a virtual reality-based mindfulness intervention, called "TRIPP," to support people with comorbid HIV and substance use disorders. This population faces significant public health challenges, as substance...
- The National Institute on Drug Abuse (NIDA) awarded a $569,743 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Yale University on July 15, 2025. The grant, titled "Y-SCORCH 2.0: Further Data Mining and Functional Characterization for Single Cell Opioid Responses in the Context of HIV (SCORCH) Program," aims to leverage advanced tools to analyze transcriptomic and epigenetic data from the SCORCH consortium and novel spatial transcriptomic data to...